Targeting Oncogenic RAS Protein
- PMID: 35830646
- DOI: 10.1056/NEJMe2206831
Targeting Oncogenic RAS Protein
Comment on
-
Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation.N Engl J Med. 2022 Jul 14;387(2):120-131. doi: 10.1056/NEJMoa2204619. Epub 2022 Jun 3. N Engl J Med. 2022. PMID: 35658005 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources